A

Researcher Profile

Anders Mellemgaard

0000-0002-9712-942x

4

Publications

1,520

Citations

10

Co-Authors

4

Active Years

Publications

Journal Article Journal of Clinical Oncology May 10, 2023

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio Vittorio Scagliotti · Purvish Parikh · Joachim von Pawel · Bonne Biesma +16 more

10.1200/jco.22.02544 18 citations

Journal Article Lung Cancer May 01, 2020

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)

Inger Johanne Zwicky Eide · Åslaug Helland · Simon Ekman · Anders Mellemgaard +5 more

10.1016/j.lungcan.2020.03.009 54 citations

Journal Article Nature Genetics Jun 12, 2017

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

James D McKay · Rayjean J Hung · Younghun Han · Xuchen Zong +135 more

10.1038/ng.3892 658 citations

Journal Article The Lancet Oncology Feb 01, 2014

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck · Rolf Kaiser · Anders Mellemgaard · Jean-Yves Douillard +10 more

10.1016/s1470-2045(13)70586-2 790 citations

Publication Timeline

2023

1

2020

1

2017

1

2014

1

Frequent Co-Authors

Joachim von Pawel

Rachel F Tyndale

Jolanta Lissowska

Adonina Tardón

Ghislaine Scelo